JPRN-UMIN000004201
Completed
未知
The evaluation of efficacy for remission maintenance with immunomodulator following remission induction with tacrolimus in patients with moderate to severe active refractory ulcerative colitis.:mucosal healing for prognosis - Hyogo College of Medicine, Osaka Medical College, Osaka City University Project 1, Tacrolimus-Ulcerative Colitis, 3 [Mucosal Healing for Prognosis] : HOOP1 (TCL-UC)-3 [MHP]
Osaka City University, Graduate School of Medicine,Department of Gastroenterology0 sites50 target enrollmentSeptember 14, 2010
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- The patients with moderate to severe active refractory ulcerative colitis
- Sponsor
- Osaka City University, Graduate School of Medicine,Department of Gastroenterology
- Enrollment
- 50
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\)The treatment with immunomodulator or anti\-TNF alpha agents within 12 weeks before administration of tacrolimus 2\)The treatment with cytapheresis within 12 weeks before administration of tacrolimus 3\)The patients who are not suitable for treatment of immunomodulator 4\)The patients after colectomy 5\)the patients with renal disorder
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
Evaluation de l'efficacité des traitements substitutifs nicotiniques (dispositifs transdermiques délivrant la nicotine pendant 16h/24h) chez 400 femmes enceintes fumeuses. Essai multicentrique, national, randomisé, contre placebo. - SNIPPDépendance nicotinique chez la femme enceinte.MedDRA version: 8.1Level: PTClassification code 10057852Term: Dépendance nicotiniqueEUCTR2006-005894-22-FRASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)
Completed
Not Applicable
therapeutic reconsolidation process model (TRP)Condition 1: Post-Traumatic Stress Disorder. Condition 2: Major Depressive Disorder.IRCT20220112053702N1Veterans Engineering and Medical Sciences Research Institute80
Recruiting
Not Applicable
A study evaluating the effect of iTBS in patient with treatment resistant depressioCTRI/2019/04/018367All India Institute of Medical Sciences New Delhi
Not yet recruiting
Not Applicable
Examination of the clinical remission and functional remission in Infliximab using the increase-in-quantity protocol to TNF-alpha inhibitory drug resistance rheumatoid arthritisrheumatoid arthritisJPRN-UMIN000014311Institute of Health Biosciences, The University of Tokushima Graduate School10
Active, not recruiting
Phase 1
Evaluation of the efficacy of antibiotic treatments associated with the Nebcine® as intravenous injection only and / or monitoring of aerosols of Tobi® in order to optimize the therapeutic management of exacerbations in patients with cystic fibrosis .EUCTR2014-003882-10-FRCHRU de Lille